Subscribe to CarissaRaman.com Subscribe to CarissaRaman.com's comments

Woensdag 22 februari, 14:16 uur

Zondag 26 februari a.s. vindt in Almere de tweede en beslissende halve finale Carlton Eredivisie plaats tussen AviAir Almere en BC DKC.

De eerste wedstrijd op 12 februari j.l. in Den Haag werd gewonnen door BC DKC. Na een spannende en gelijkopgaande halve finale leek AviAir Almere met een 4-2 voorsprong op weg naar de winst, maar  BC DKC wist toch de stand weer gelijk te trekken en de 4-4 op het bord te zetten. De golden game werd daarna door BC DKC gewonnen.

De winnaar over beide halve finales speelt op zaterdag 11 maart in de Maaspoort Sports Events in ‘s-Hertogenbosch de Finale Landskampioenschap Carlton Eredivisie tegen de huidige landskampioen en bekerwinnaar Van Zundert/VELO. Die zich als nummer één van de competitie rechtstreeks hiervoor wist te plaatsen.

Halve finale zondag 26 februari:                         

13.00 uur: AviAir Almere – BC DKC         https://www.bvalmere.nl/nieuws…http://www.bcdkc.nl/51-nieuws/…

Klik hier om alle resultaten van de eerste halve finale Carlton Eredivisie terug te vinden.

Article source: http://www.badminton.nl/nieuws/26-februari-aviair-almere---bc-dkc-2e-halve-finale-carlton-eredivisie


Wie: Michiel Muller

Onderneming: Picnic

Werknemers: 400, inclusief flexwerkers

Michiel Muller is momenteel druk bezig met de uitbreiding van Picnic en alles wat daarbij komt kijken. Het bedrijf is nu actief in zes plaatsen, maar daar moeten er dit jaar tien tot vijftien bij komen.

Ook wordt gezocht naar een nieuw distributiecentrum, want het huidige centrum kan de groei niet aan. In eerste instantie wordt een tweede distributiecentrum in bedrijf genomen naast het eerste, en later wordt een compleet nieuw centrum gebouwd.

De komende drie jaar hoopt Picnic in hetzelfde tempo door te groeien. “We denken tegen die tijd zo’n drie kwart van de Nederlandse bevolking te kunnen bedienen”, aldus Muller.

Roeien

Muller, die in zijn ondernemerscarrière onder meer betrokken was bij Tango en Route Mobiel, staat elke ochtend rond 6.45 uur op. “Dan ga ik meestal even roeien. Ik heb thuis zo’n apparaat staan, best handig. Daarna ga ik ontbijten en kijk ik in Slack wat er afgelopen nacht en ochtend al gaande was. Ik lees het FD, beantwoord een paar mailtjes en dan stap ik in de auto.”

“Ik woon in Rotterdam, maar ons kantoor staat in Amsterdam en het distributiecentrum in Nijkerk, dus meestal ben ik wel een stukje aan het rijden. Ook ben ik regelmatig onderweg naar onze hubs in Amersfoort, Utrecht en Almere. Die tijd gebruik ik vaak om wat telefoontjes af te handelen, dat werkt prima.”

Wat er daarna gebeurt, verschilt per dag. “Regelmatig zitten we met het growth team bij elkaar. Dat team houdt zich bezig met groei in bestaande steden, maar ook met de uitbreiding naar nieuwe plekken.”

Aanloop

Muller startte Picnic in 2015 met drie compagnons. Elke maandag is er een vergadering met alle oprichters. “We nemen de week door, kijken naar de financiën en naar investeringen.”

Verder overlegt Muller regelmatig met de CTO van Picnic, onder meer over het werven van nieuw personeel. “Er zijn verschillende tech events waar wij op podia staan. Het is belangrijk dat mensen ons weten te vinden. Wij sourcen personeel over de hele wereld, ik denk dat maar 30 procent van onze werknemers uit Nederland komt. Gelukkig hebben we niet te klagen over aanloop.”

Megaveel kansen

Alles gaat bij Picnic in een “behoorlijk tempo”. Daarmee wil Muller aangeven dat er veel ontwikkelingen zijn in de online boodschappenmarkt en dat van het team veel wordt verwacht, bijvoorbeeld dat ze flexibel zijn met werktijden.” Ook hijzelf werkt vrijwel dagelijks buiten kantooruren. “Ik werk altijd ‘s avonds, dat is niet te voorkomen. Niet elke avond tot heel laat, maar ik ben wel elke avond met werk bezig.” 

“Van hard werken is nog nooit iemand ziek geworden”, meent Muller. “Als mensen last hebben van een te hoge werkdruk komt dat vaak omdat ze dingen doen die ze niet leuk vinden. Maar als ik bij Picnic het idee heb dat iemand te veel werkt, zeg ik weleens dat hij of zij een avondje vroeg naar huis moet.”

“Het leuke aan ons bedrijf is ook dat je veel zelf kunt ontdekken en megaveel kansen krijgt. Ik wil mensen niet te veel programmeren en net doen alsof ik de wijsheid in pacht heb: als jong bedrijf moet je van jong talent gebruikmaken. Dat betekent ook dat je moet luisteren naar je mensen en de vraag terug moet stellen: wat vind jij daar eigenlijk van? Iedereen moet z’n hersenen mee laten werken.”

Lees andere interviews in deze rubriek

Article source: http://www.nu.nl/ondernemen/4486356/picnic-van-hard-werken-nog-nooit-iemand-ziek-geworden.html


WASHINGTON (CNN) — President Donald Trump visited the National Museum of African American History and Culture for the first time on Tuesday morning.

“Honestly, it is fantastic. They’ve done an incredible job,” Trump said during brief comments before reporters.

He was joined by daughter, Ivanka Trump, Housing and Urban Development nominee Ben Carson and his wife, Candy Carson, Sen. Tim Scott, R-South Carolina, and presidential aide and former “Apprentice” contestant Omarosa Manigault, among others.

The visit was arranged by Manigault, a source familiar with the visit said. The source added that the visit was originally penciled in for mid-January but was effectively nixed at that time by the Secret Service, citing security concerns.

Trump’s visit to the museum, which opened last September, coincides with Black History Month. Trump first marked the event at the beginning of the month hosting a listening session with what the White House described as African-American leaders.

National Museum of African American History and Culture

Wikipedia

National Museum of African American History and Culture

The attendees did not include leaders from top African-American advocacy groups such as the NAACP or the National Urban League, but instead featured Trump sitting alongside several of his campaign’s top black supporters and members of his administration, including Carson and Manigault.

Last week, Trump again drew questions as he touted his outreach efforts, claiming that Rep. Elijah Cummings, a Democratic member of the Congressional Black Caucus, canceled a meeting with Trump because it would be “bad politics.”

Cummings said the story was completely false and that the Congressional Black Caucus had tried to set up a meeting with Trump through the White House without success.

Trump also drew criticism when during his news conference last week asked April Ryan, a veteran White House reporter who is black, if she would help set up a meeting with the black caucus, which Ryan is not affiliated with.

Trump is the second member of the first family to attend the months-old museum in just a week. First lady Melania Trump visited the museum last week with Sara Netanyahu, wife of the Israeli Prime Minister Benjamin Netanyahu.

Trump made a concerted effort to reach out to African-American voters during the campaign, including through events hosted by his National Diversity Coalition and alongside Carson, the prominent black neurosurgeon who endorsed Trump after dropping out of the GOP primary race.

But Trump’s black outreach often came under fierce criticism during the campaign.

With the exception of two visits to predominantly black churches — one in Michigan and one in Ohio — Trump largely delivered his message of outreach to African-Americans before overwhelmingly white audiences at political rallies around the country.

His description of African-American life was also often exceedingly dark and broad-brushed, as he equated the lives of poor African-Americans living in inner cities with those of all African-Americans, most of whom do not live in dire straits.

In a frequent refrain, Trump argued that African-Americans lived in conditions worse than those in many foreign war zones and pointedly called on those in the typically Democratic voting bloc to take a risk and support him.

“What the hell do you have to lose?” Trump often asked.

CNN’s Joe Johns and Noah Gray contributed to this report.

Article source: http://amsterdamnews.com/news/2017/feb/21/trump-african-american-history-museum-fantastic/


This was repeated in 1934 with 1,500 participating. State angling champion Charles Moulton demonstrated casting techniques, plus more films and lectures occurred. This second one-night “sportsmen’s show” was so successful that Todd and his associates needed more space. Todd convinced the Board of Education to allow use of Amsterdam’s Theodore Roosevelt Junior High School during Easter recess. The Board agreed, and the shows grew yearly.

The 1935 show drew 1,800 visitors and the school’s large cafeteria facilities allowed league volunteers to continue serving pancake dinners. By 1937, it was necessary to present two shows, and those unable to find auditorium seats for the first were invited to wait in the gym. To keep those waiting entertained, log sawing and splitting contests between area lumberjacks were staged. Fulton county’s Alex Drozinski won the log splitting contest.

1938 brought more expansion. Classrooms were co-opted for wildlife exhibits, Fulton County’s Stanley “Slim” DeVoe and his Bark Peelers entertained, and gym attractions now included casting and archery demonstrations. The Mohawk Valley Kennel Club exhibited hunting dogs and trick shooter Bill Jacoby demonstrated his skills. These gym activities now outdrew the lectures and films.

League member volunteerism was key to the show’s success. To quote the April 19th 1949 Recorder, “Members of the club do all the show work for nothing, from the preliminary planning, through the shaping of a program, and setting up the auditorium and gymnasium, to tearing it down when the final performance is over.”

In 1939, the league purchased a 25 by 35 foot, four-foot deep canvas pool, erecting it in the middle of the gym. This made exciting log rolling and canoe tilting contests possible, nor were contestants amateurs. Competitions were officially sanctioned by the New York State Lumberman’s Association, and contestants strove to set new official records in the sawing, splitting and rolling events. That year, “Fred Fuelner of Middle Grove chopped a 12 inch pine log in 32 and 2/5th seconds.” Fuelner and Leland Marcellus of Greenfield Center sawed through a 14-inch pine log using a two-man crosscut saw in 10 and ½ seconds, a new record. The event expanded to three nights, with an attendance of 5,800 and “hundreds turned away.”

The sportsmen’s show was now a real moneymaker, and in 1940 the league added a fourth night with more entertainment. Quoting the program, they featured, “Sling Shot Charlie from Tennessee, Edna Alee, Champion Lady Pistol Shot from Denver, canoe builder Pete Spencer from Old Town Maine, and champion Canadian long-distance musher Jacques Suzanne and his sled dogs.” Axe throwing, log rolling and archery competitions continued, boosting attendance to 8,500.

After expanding to five nights in 1941, “Junior High was packed every night. New lumberjack records were set and everyone had a good time, including the overworked club members. Attendance reached 10,000.”

Attendees packed area restaurants and hotels from Herkimer to Schenectady. The 1942 show was already booked when we entered the war, so it went forward, with attendance surpassing 12,000, after which shows were suspended until 1946. Perhaps tired Fish and Game League members needed the break, but they produced another successful show in 1946 before skipping 1947 because coal shortages precluded use of the school. Nineteen forty-eight’s and forty-nine’s shows ran eight nights, forty-nine’s featuring explorer David Irwin, who in 1935 trekked 2,000 miles across the Arctic, and Irwin brought an Eskimo family with him. As Eskimos and arctic explorers weren’t common sights in upstate New York, ’49’s show made even more money, which begs the question, how was it used?

According to the 1948 program pictured, the League provided funding to release 5,200 brown trout into five Fulton County streams and 2000 brook trout in two others, releasing an additional 10,000 into Montgomery, Hamilton and Warren county streams. Nine hundred dollars purchased 600 rabbits, released into area woods designated by the Conservation Department. Remaining profits went to Fulton and Montgomery county Boy and Girl Scout Councils.

Unfortunately, after 1949’s very successful show, including Adirondack hermit Noah Rondeau and a wrestling bear act, the event suddenly declined. League membership dwindled, although remaining members held a one-night show for members of the Mayfield, Piseco and Wells game clubs at Junior High on April 9th, 1950. Much like the original 1933 event, it consisted of supper, films, lectures, and ‘Slim’ DeVoe’s country band.

April 17 1953’s Recorder quoted Amsterdam Fish and Game League President Dick Louer as follows: “This show was once a nationally-known event.

In recent years, obstacles arose and prevented its presentation. A large number of enthusiasts have been disappointed by discontinuance of the show.” The main obstacle was that private promotors, wishing to run for-profit shows, complained to the State Education Department about the Amsterdam league’s free use of junior high. State officials agreed, forcing discontinuance of events at the school. One-night shows occurred elsewhere in 1957 and ’58, but after that, the league was apparently no longer game.

Article source: http://www.leaderherald.com/news/community-news/2017/02/amsterdam-sportsmens-shows-once-created-great-area-interest/



Chalet-RITUAL-Justin-Massei

Whether within the daily mundane, spiritual, or creative realms, ritual helps to clear mental space, focus intentions, and rejuvenate the mind.

Such is the ethos of a promising new event series in the world’s clubbing capital, Berlin. Headed up by the city’s own Justin Massei, RITUAL is a party that attempts to pull closer, delve deeper, and conjure the unseen that connects humanity. The organically driven approach to the events features the full immersive experience with music and decor.

The first edition lands 23 February with Diymanic‘s Einmusik, Justin Massei and BASH.

Justin Massei’s “Sideways Eight” EP is out next month on Selador featuring remixes from Ruede Hagelstein and AFFKT

ritual-berlin

23 February | Ritual | Tickets | Chalet, Berlin

Click here to scroll down to the comments

Related Post


dha-mix-262-mat.joe

DHA Mix #262 By Mat.Joe


dha-mix-256-marc depulse

DHA Mix #256 By Marc DePulse


premiere-till von sein-forever-original-mix

Premiere: Till von Sein – Forever (Original Mix)


mix-249-klangkuenstler

DHA Mix #249 By KlangKuenstler


About The Author

Our favorites

Article source: http://www.deephouseamsterdam.com/atmospheric-berlin-concept-ritual/


TXF Singapore 2017

TXF is returning to this global trade hub to bring together a network of buyers, sellers, financiers and facilitators for another year of innovative sessions and lively debate!

Article source: http://www.txfnews.com/Ticker/Redirect/5dfa2054-fb97-4f74-8969-c185aaee81f7?ShowSmallPage=True


The first wave of names has landed for Applesap Festival in Amsterdam.

The hip-hop focused event has grown from free parties in the early 2000s to one of the biggest events in the Dutch calendar, bringing together local talents and international heavyweights.

This year, they’ve secured a headline set from Lil Wayne, which is a pretty massive deal. Wayne hasn’t played Europe very much at all over the last 10 years. This announcement gives some weight to the speculation that Drake may be hosting some kind of Young Money reunion in the UK this summer.

Below Wayne, prodigious London rapper Dave and Brixton rap collective 67 will both perform as well as popular DJ and entrepreneur Siobhan Bell.

They are joined by a selection of talents from the Dutch scene like Kempi and Yung Nnelg.

Applesap Fresh Music Festival takes place on 12 August 2017 at Flevopark, Amsterdam. Find more information and ticket options here.

Check out the full lineup below.

Lil Wayne (US)
Dave (UK)
Kempi
Yung Nnelg
67 (UK)
Jarreau Vandal
Siobhan Bell (UK)
Vic Crezée
Mairo Nawaz
Rotjoch United
Fresku, Mocromaniac, Pietju Bell, Woenzelaar, Killer Kamal, Braz
Kid de Blits

Article source: http://crackmagazine.net/2017/02/lil-wayne-dave-67-announced-appelsap-festival-amsterdam/


AMSTERDAM–(BUSINESS WIRE)–Regulatory News:

Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”)
(Euronext Amsterdam and Brussels: KDS)
, a clinical stage
biopharmaceutical company developing innovative T-cell immunotherapy
treatments for blood cancers and inherited blood disorders, today
announces that it will hold an Extraordinary General Meeting of
shareholders in order to consider and vote on, among other matters, the
proposal to appoint Mr. Arthur Lahr as statutory director on April 4,
2017 at 10:00 CET at the Amsterdam Stock Exchange (Euronext), Beursplein
5, 1012 JW Amsterdam, The Netherlands.

The notice and agenda for the EGM as well as the proxy form are
available on the Investors’ section of the Kiadis Pharma website at: http://www.kiadis.com/investors/shareholders-meetings/.

About Kiadis Pharma

Kiadis Pharma is focused on cell-based immunotherapy products for the
treatment of blood cancers and inherited blood disorders. The Company’s
products have the potential to address the risks and limitations
connected with allogeneic hematopoietic stem cell transplantation
(HSCT), namely Graft-versus-Host-Disease (GVHD), cancer relapse,
opportunistic infections and limited matched donor availability. The
Company believes that HSCT could become a first-choice treatment for
blood cancers, inherited blood disorders and possibly autoimmune
diseases and solid organ transplantations.

On December 5, 2016 at the Annual Meeting of the American Society of
Hematology (ASH), the Company reported positive Phase II results with
its lead product ATIR101™ in patients with blood cancer. The data showed
that ATIR101™ significantly reduced Transplant Related Mortality and
significantly improved Overall Survival. In addition, ATIR101™ did not
elicit grade III-IV GVHD in any patient. Based on these positive
results, a Phase III clinical trial has been initiated. ATIR101™ has
been granted Orphan Drug Designations both in the US and Europe.

The Company’s second product candidate, ATIR201™, addresses inherited
blood disorders with an initial focus on thalassemia, a disease which
results in destruction of red blood cells in patients. ATIR201™ Phase
I/II clinical development has been initiated recently.

Kiadis Pharma, based in Amsterdam, The Netherlands, was granted an
Advanced Therapy Medicinal Product (ATMP) certificate for manufacturing
quality and non-clinical data by the European Medicines Agency (EMA).
The Company’s shares are listed on Euronext Amsterdam and Euronext
Brussels. For more information visit www.kiadis.com

Forward Looking Statements

Certain statements, beliefs and opinions in this press release are
forward-looking, which reflect Kiadis Pharma’s or, as appropriate,
Kiadis Pharma’s directors’ current expectations and projections about
future events. By their nature, forward-looking statements involve a
number of risks, uncertainties and assumptions that could cause actual
results or events to differ materially from those expressed or implied
by the forward-looking statements. These risks, uncertainties and
assumptions could adversely affect the outcome and financial effects of
the plans and events described herein. A multitude of factors including,
but not limited to, changes in demand, competition and technology, can
cause actual events, performance or results to differ significantly from
any anticipated development. Forward looking statements contained in
this press release regarding past trends or activities should not be
taken as a representation that such trends or activities will continue
in the future. As a result, Kiadis Pharma expressly disclaims any
obligation or undertaking to release any update or revisions to any
forward-looking statements in this press release as a result of any
change in expectations or any change in events, conditions, assumptions
or circumstances on which these forward-looking statements are based.
Neither Kiadis Pharma nor its advisers or representatives nor any of its
subsidiary undertakings or any such person’s officers or employees
guarantees that the assumptions underlying such forward-looking
statements are free from errors nor does either accept any
responsibility for the future accuracy of the forward-looking statements
contained in this press release or the actual occurrence of the
forecasted developments. You should not place undue reliance on
forward-looking statements, which speak only as of the date of this
press release.

Article source: http://www.businesswire.com/news/home/20170219005052/en/Kiadis-Pharma-notice-Extraordinary-General-Meeting-shareholders



3 ways startups can slash operating costs

One of the more expensive aspects of running a business revolves around handling money. Yes, a budget is important. But, even more important, is how much it costs for an enterprise to move their money around.

After all, just because you know how to generate revenue, doesn’t mean …

Article source: https://thenextweb.com/insider/2017/02/20/inside-tnw-why-it-works/


AMSTERDAM–(BUSINESS WIRE)–

Regulatory News:

Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders, today announces that it will hold an Extraordinary General Meeting of shareholders in order to consider and vote on, among other matters, the proposal to appoint Mr. Arthur Lahr as statutory director on April 4, 2017 at 10:00 CET at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands.

The notice and agenda for the EGM as well as the proxy form are available on the Investors’ section of the Kiadis Pharma website at: http://www.kiadis.com/investors/shareholders-meetings/.

About Kiadis Pharma

Kiadis Pharma is focused on cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The Company’s products have the potential to address the risks and limitations connected with allogeneic hematopoietic stem cell transplantation (HSCT), namely Graft-versus-Host-Disease (GVHD), cancer relapse, opportunistic infections and limited matched donor availability. The Company believes that HSCT could become a first-choice treatment for blood cancers, inherited blood disorders and possibly autoimmune diseases and solid organ transplantations.

On December 5, 2016 at the Annual Meeting of the American Society of Hematology (ASH), the Company reported positive Phase II results with its lead product ATIR101™ in patients with blood cancer. The data showed that ATIR101™ significantly reduced Transplant Related Mortality and significantly improved Overall Survival. In addition, ATIR101™ did not elicit grade III-IV GVHD in any patient. Based on these positive results, a Phase III clinical trial has been initiated. ATIR101™ has been granted Orphan Drug Designations both in the US and Europe.

The Company’s second product candidate, ATIR201™, addresses inherited blood disorders with an initial focus on thalassemia, a disease which results in destruction of red blood cells in patients. ATIR201™ Phase I/II clinical development has been initiated recently.

Kiadis Pharma, based in Amsterdam, The Netherlands, was granted an Advanced Therapy Medicinal Product (ATMP) certificate for manufacturing quality and non-clinical data by the European Medicines Agency (EMA). The Company’s shares are listed on Euronext Amsterdam and Euronext Brussels. For more information visit www.kiadis.com

Forward Looking Statements

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect Kiadis Pharma’s or, as appropriate, Kiadis Pharma’s directors’ current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, Kiadis Pharma expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based. Neither Kiadis Pharma nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170219005052/en/

Article source: http://finance.yahoo.com/news/kiadis-pharma-notice-extraordinary-general-060000376.html